Non-small cell lung cancer is a common malignant tumor with soaring incidence and mortality rates. Although various existing treatment methods have extended the survival period of patients, the prognosis remains poor. Therefore, standardizing the Tertiary prevention strategy for lung cancer is extremely crucial. The Tertiary prevention strategy for lung cancer is divided into: primary cause prevention, secondary early prevention, and tertiary clinical prevention. Curcumin has become a hotspot in lung cancer prevention due to its broad biological activity and low toxicity. Derived from turmeric, it possesses various pharmacological activities, capable of inhibiting lung cancer cell proliferation, inducing apoptosis, and resisting invasion and metastasis, showing significant anti-tumor potential, and has application potential in the Tertiary prevention of lung cancer. This article reviews the latest achievements of curcumin and its combination with chemotherapy drugs from January 2010 to January 2025 in databases such as PubMed and CNKI, elucidating its multifaceted roles in the Tertiary prevention strategy of lung cancer. However, curcumin faces issues such as rapid metabolism, poor oral bioavailability, and limited water solubility, slightly hindering its clinical application, but it still holds promise as a potential medication or auxiliary means for theTertiary prevention of non-small cell lung cancer.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |